After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

The Romans created a remarkably organized and well-structured society. A big part of that was writing; they wrote often, and ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...

A University of Warwick epigraphy expert has collaborated with Google DeepMind to evaluate "Aeneas," an AI model that ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted. Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...